A new immune system regulator has been discovereD. This is the key factor that controls the development of regulatory T cells. The research forms the basis for exploring new treatment of cancer and immune-mediated diseases. The findings emerged from a study at Turku Centre for Biotechnology of the University of Turku and Åbo Akademi University in Finland.
Regulatory T cells are critical controllers of the immune response. The majority of T cells boost the immune response enhancing the ability to destroy cancer cells, viruses and bacteria. In contrast, regulatory T cells can sometimes suppress the immune system's ability to attack cancer cells, allowing cancer to grow and spread. In these instances, inhibiting or braking the regulatory T cell activity would be needed.
Interstitial Cystitis
Interstitial cystistis is an umbrella term where a pathology cannot be defined but the patient suffers from recurring, pain in the pelvic region along with other symptoms including frequency or urgency in urination
"We discovered that a protein called 'Hypermethylated In Cancer 1', or HIC1, serves as the key regulator of regulatory T cells controlling the expression of a large set of genes contributing to T cell function," says Academy Professor Riitta Lahesmaa.
Source: Eurekalert
Remedies for Seasonal Allergy Relief
Understanding the cause and mechanism of seasonal allergy can help in choosing the right treatment.
 Researchers Identify Gene Responsible for Production and Growth of Fat CellsWhen the gene was silenced, it resulted in a 50% reduction in the amount of 'white fat', the kind associated with obesity, heart disease and diabetes. | Advertisement
|
How Do Fat Cells Respond to Your Breakfast Eating Habits?
Eating breakfast Regularly may affect our fat cells by decreasing the activity of genes involved in fat metabolism found a new study
Recommended Readings
Latest Clinical Trials News
